Korean-manufactured hyaluronic acid fillers have become a major category in the UK aesthetics trade over the past decade, sitting alongside long-established European and US brands. Here's the category context, and where Regenovue fits.
Why Korean fillers gained ground
South Korea has a large domestic aesthetics manufacturing sector, and its export brands typically reach UK clinics at a lower trade price point than legacy Western brands. That price-to-specification balance — cross-linked, non-animal HA gels at accessible wholesale cost — is the core commercial appeal for clinics managing per-treatment margins.
The main Korean lines UK clinics stock
Among the Korean ranges we distribute, Revolax is the most widely recognised, with Regenovue and Aessoa also established options — all following similar tiered-consistency structures. See our Regenovue vs Revolax comparison for a closer look.
Where Regenovue sits
Regenovue occupies the accessible end of the category with a clean three-tier range — explained here — making it a straightforward line for clinics to trial alongside existing stock. As ever, product choice for any treatment is a clinical decision for the qualified practitioner.
Log in to view trade pricing across all our dermal filler lines — free express delivery on trade orders over £500.
For trained, qualified and insured aesthetic practitioners only. SK Clinical Distributions supplies trade customers; products are not for sale to the public. Nothing in this article constitutes medical advice; practitioners remain responsible for verifying each product's regulatory status and intended use.